Physician profile
Jodi F Marshall
NPI 1710093174
$1,864.55
in general payments reported to CMS, 2019-2025
11 companies · $866 in 2025
The $866 reported for 2025 was more than what 81% of Geriatric Psychiatry providers received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $163 · 2022: $306 · 2023: $225 · 2024: $305 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,396.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $499.01 | 2023-2025 | Rexulti, Brintellix |
| Janssen Pharmaceuticals, INC | $498.44 | 2021-2025 | Spravato, Invega Sustenna |
| Axsome Therapeutics, INC. | $299.46 | 2024-2025 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $223.33 | 2024-2025 | Cobenfy |
| Alkermes, INC. | $161.36 | 2025 | Aristada, Lybalvi |
| Abbvie INC. | $88.97 | 2023-2025 | |
| Vanda Pharmaceuticals INC. | $28.73 | 2022-2024 | Fanapt |
| Neurocrine Biosciences, INC. | $18.99 | 2025 | |
| Indivior INC. | $16.44 | 2023 | Sublocade |
| Teva Pharmaceuticals USA, INC. | $15.15 | 2025 | Uzedy |
| Integra Lifesciences Corporation | $14.67 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.